Related Experiment Video

Updated: Jun 20, 2026

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat
07:42

An Image Guided Transapical Mitral Valve Leaflet Puncture Model of Controlled Volume Overload from Mitral Regurgitation in the Rat

Published on: May 19, 2020

Neurohormonal activation in canine degenerative mitral valve disease: implications on pathophysiology and treatment

M A Oyama1

  • 1Department of Clinical Studies-Philadelphia, School of Veterinary Medicine, University of Pennsylvania, 3900 Delancey St., Philadelphia, PA 19107, USA.

The Journal of Small Animal Practice
|September 22, 2009
PubMed

Insights

Neurohormonal systems significantly impact canine degenerative mitral valve disease (DMVD). Understanding these pathways is key to developing effective treatments for this common heart condition in dogs.

Area of Science:

  • Veterinary Cardiology
  • Canine Pathophysiology

Background:

  • Canine degenerative mitral valve disease (DMVD) is a prevalent condition leading to heart failure.
  • Mitral regurgitation in DMVD causes reduced cardiac output and elevated heart pressures.
  • Neurohormonal activation is a key consequence of these hemodynamic changes.

Purpose of the Study:

  • To elucidate the role of neurohormonal systems in the progression of canine DMVD.
  • To highlight how understanding neurohormonal mechanisms can inform therapeutic strategies.

Main Methods:

  • Review of existing literature on canine DMVD and neurohormonal pathways.
  • Analysis of the pathophysiological cascade from mitral regurgitation to neurohormonal activation.
  • Examination of current medical therapies targeting neurohormonal systems.

Main Results:

  • Neurohormonal systems are critically involved in the maladaptive cardiac remodeling seen in DMVD.
  • These systems contribute to congestion, morbidity, and mortality in affected dogs.
  • Established therapies like ACE inhibitors and spironolactone function by modulating these responses.

Conclusions:

  • Targeting neurohormonal pathways offers a rational basis for treating canine DMVD.
  • Further research into these mechanisms may reveal novel therapeutic targets.
  • A comprehensive understanding of neurohormonal involvement is essential for improving outcomes in dogs with DMVD.

More Related Videos

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice12:12

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice

Published on: February 14, 2017

Related Concept Videos

Mitral Valve Prolapse I: Introduction01:27

Mitral Valve Prolapse I: Introduction

IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...